Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Hilde
Hilde Angelfoss, Skodje NO
| Patent application number | Description | Published |
|---|---|---|
| 20110095593 | DEVICE FOR A CHILD'S CHAIR - A glider device for a leg of a chair, especially a leg of a chair for a children's chair, comprising a plate which comprises at least one fastening opening and wherein the plate has one smooth underside and a topside, characterized in that it may be fastened in at least two different length positions in relation to the leg of the chair it is fastened to, and that it in both positions has a horizontal extent which is larger than the area it covers on the leg of the chair. A safety kit comprising the glider device and the use of the same is also disclosed. | 04-28-2011 |
Hilde Azijn, Leuven BE
| Patent application number | Description | Published |
|---|---|---|
| 20090061420 | MUTATIONAL PROFILES IN HIV-1 PROTEASE CORRELATED WITH PHENOTYPIC DRUG RESISTANCE - The present invention is directed to the field of nucleic acid diagnostics and the identification of base variation in target nucleic acid sequences. More particularly, the present invention relates to the use of such genotypic characterization of a target population of HIV and the subsequent association, i.e., correlation, of this information to phenotypic interpretation in order to correlate virus mutational profiles with drug resistance. The invention also relates to methods of utilizing the mutational profiles of the invention in drug development, i.e., drug discovery, drug design, drug modification, and therapy, treatment design, clinical management and diagnostic analysis | 03-05-2009 |
| 20100009341 | METHODS AND MEANS FOR ASSESSING HIV GAG/PROTEASE INHIBITOR THERAPY - The present invention relates to methods and means for the evaluation of HIV treatment. In particular, molecular events at the HIV gag and protease proteins and their effect on therapeutic efficacy of drugs are determined The methods rely on providing HIV gag and protease nucleic acid material and evaluating a treatment either through genotyping or phenotyping. Said method may find use in multiple fields including diagnostics, drug screening, pharmacogenetics and drug development. | 01-14-2010 |
Hilde Bekier-Larssen, Oslo NO
| Patent application number | Description | Published |
|---|---|---|
| 20100176015 | Hanger for cutting tool - A hanger for being secured on a cutting tool ( | 07-15-2010 |
Hilde Buydts, Bornem BE
| Patent application number | Description | Published |
|---|---|---|
| 20110064802 | IMPROVED CAPSULE WITH AIR-VENTS - The invention relates to a capsule comprising a hollow tubular body ( | 03-17-2011 |
Hilde Cheroutre, Del Mar, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090136470 | REGULATORY T CELLS AND METHODS OF MAKING AND USING SAME - Methods of stimulating or increasing differentiation to regulatory T cells, cultures of regulatory T cells and methods of reducing or decreasing an immune response, inflammation or an inflammatory response, among other things, are provided. Methods include, among other things, contacting blood cells or T cells with an amount of TGF-beta or a TGF-beta analogue and a retinoic acid receptor agonist, or an amount of a retinoid X receptor (RXR) or peroxisome proliferator activated receptor-gamma (PPARgamma) agonist, sufficient to stimulate or increase differentiation to regulatory T cells. Cultures of regulatory T cells include T cells that express a marker associated with regulatory T cells, such as cultures in which regulatory T cells represent, for example, 30% or more of the total number of cells in the culture. | 05-28-2009 |
Hilde De Henau, Beveren-Waas BE
| Patent application number | Description | Published |
|---|---|---|
| 20090017456 | DETECTION, IDENTIFICATION AND DIFFERENTIATION OF EUBACTERIAL TAXA USING A HYBRIDIZATION ASSAY - The present invention relates to a method for the specific detection and/or identification of | 01-15-2009 |
Hilde Krikor, Deurne BE
| Patent application number | Description | Published |
|---|---|---|
| 20100196646 | DRY BLEND HAVING OXYGEN-SCAVENGING PROPERTIES, AND THE USE THEREOF FOR MAKING A MONOLAYER PACKAGING ARTICLE - For making a monolayer packaging article having O | 08-05-2010 |
| 20110244155 | Polymeric Material for Making a Packaging Article Having Oxygen-Barrier Properties and Low Light Transmission Properties - The polymeric material having oxygen barrier properties and low light transmission characteristics, in particular within the UV and visible light wavelengths and comprises (A) a polyester, (B) mineral particles, (C) a polyamide, and (D) at least one transition metal catalyst. Preferably the amount of mineral particles is not more than 26 wt % of the total weight of the material, and is not less than 20 wt % of the total weight of the material. | 10-06-2011 |
Hilde Laeremans, Maastricht NL
| Patent application number | Description | Published |
|---|---|---|
| 20120014876 | ANTAGONISTIC PEPTIDES FOR FRIZZLED-1 AND FRIZZLED-2 - The invention is in the field of molecular medicine. It provides antagonistic compounds for frizzled 1 and/or frizzled 2 receptors, which may be useful in molecular imaging of the wound healing process after myocardial infarction and in therapeutic intervention into wound healing after remodeling of the heart, thereby ameliorating the consequences of myocardial infarction. The invention provides a method for antagonizing frizzled-1 or frizzled-2 receptors, wherein the receptor is contacted with a composition comprising a linear fragment of Wnt3(a) or Wnt5a or a functional analogue thereof, which comprises at least one cysteine residue, one threonine residue, one aspartic acid residue and one glycine residue. | 01-19-2012 |
Hilde Riethmuller-Winzen, Frankfurt DE
| Patent application number | Description | Published |
|---|---|---|
| 20080255053 | METHOD FOR THE THERAPEUTIC MANAGEMENT OF ENDOMETRIOSIS - The present inventions provides a method for therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction by short term induction treatment with an LH-RH antagonist for 4 to 12 weeks. According to another aspect of the present invention, the short term LH-RH treatment is followed by the combined or separate administration of one or more active agents selected from the group consisting of a contraceptive, preferably an oral contraceptive, a non-steroidal anti-rheumatic agent, an analgetic, an androgen other than a 17-alpha-alkyl substituted testosterone or any combinations thereof. According to a further aspect of the present invention a pharmaceutical composition comprising an LHRH antagonist and one ore more active agents selected from the group consisting of a contraceptive, preferably an oral contraceptive, a non-steroidal anti-rheumatic agent, an analgetic, an androgen other than a 17-alpha-alkyl substituted testosterone or any combinations thereof are provided. | 10-16-2008 |
Hilde Schoofs, Halen BE
Hilde Stals, Gent BE
| Patent application number | Description | Published |
|---|---|---|
| 20110117113 | IMMUNOGLOBULIN SINGLE VARIABLE DOMAIN DIRECTED AGAINST HUMAN CXCR4 AND OTHER CELL ASSOCIATED PROTEINS AND METHODS TO GENERATE THEM - The invention relates to immunoglobulin single variable domains directed against specific human CXCR4 epitopes (herein also referred to interchangeably as “compounds of the invention”, “amino acid sequences of the invention”, or “building blocks of the invention”) and polypeptides comprising them (herein also referred to as “polypeptides of the invention”, “compounds of the invention”, or “constructs of the invention”). | 05-19-2011 |
Hilde Steinmoen, Fyllingsdalen NO
| Patent application number | Description | Published |
|---|---|---|
| 20100047384 | METHODS OF PRODUCING TRANSFORMATION COMPETENT BACTERIA - A method of producing transformation competent bacteria, comprising the steps of: (i) transforming a bacteria that is not naturally transformation competent with a plasmid, wherein said plasmid comprises a comX gene sequence encoding a ComX protein or functional part or derivative or variant thereof under the regulatory control of a promoter which is inducible by a transcription initiator, (ii) contacting said transformed bacteria with said transcription initiator to initiate transcription of said comX gene sequence is provided. Also provided are plasmids, transformed bacteria, transformation competent bacteria, mutant bacteria and food products comprising said mutant bacteria. | 02-25-2010 |
Hilde Valø, Asker NO
| Patent application number | Description | Published |
|---|---|---|
| 20090184865 | Method and system for automatic classification of objects - A new method has been developed as an attempt to improve speed and robustness of existing ISAR classification methods. The new method produces a set of silhouettes of possible models in a 3D model database. The set of silhouettes of each model views the model from various viewing angles, as the target dimensions will vary as it is viewed from different angles. The silhouettes are stored as a training set. Classification is done by comparing the silhouette of the target with the set of silhouettes in the training set. The silhouettes are calculated prior to the silhouette matching. | 07-23-2009 |
Hilde Van Grinderbeek, Vilvoorde BE
| Patent application number | Description | Published |
|---|---|---|
| 20110212149 | PUFFED STARCH MATERIAL - The present invention concerns a puffed popcorn starch containing powder having a loose bulk density of less than 120 g/L and a particle size smaller than 1 mm, a non-aqueous liquid-loaded starch material comprising said powder and a process for preparing these. In addition the present invention relates to the use of said powder as a solid carrier material for non-aqueous liquid or gaseous components and the use of said non-aqueous liquid-loaded starch material in food and animal feed products, pharmaceuticals, nutraceuticals, agrochemicals, and cosmetic or personal care products. | 09-01-2011 |